Dynavax Technologies Corp
NASDAQ:DVAX

Watchlist Manager

Dynavax Technologies Corp

NASDAQ:DVAX

Watchlist

Dividends

Price: 12.66 USD 1.36% Market Closed

Market Cap: 1.7B USD

Have any thoughts about
Dynavax Technologies Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 12.66 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DVAX Alert

Dynavax Technologies Corp

12.66

+0.17 (+1.36%)

52 Week Range	10.05 14.98
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Dynavax Technologies Corp

What unique competitive advantages
does Dynavax Technologies Corp hold over its rivals?

What risks and challenges
does Dynavax Technologies Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Dynavax Technologies Corp.

What unique competitive advantages
does Dynavax Technologies Corp hold over its rivals?

What risks and challenges
does Dynavax Technologies Corp face in the near future?

Has there been any significant insider trading activity
in Dynavax Technologies Corp recently?

Summarize the latest earnings call
of Dynavax Technologies Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dynavax Technologies Corp.

Provide P/S
for Dynavax Technologies Corp.

Provide P/E
for Dynavax Technologies Corp.

Provide P/OCF
for Dynavax Technologies Corp.

Provide P/FCFE
for Dynavax Technologies Corp.

Provide P/B
for Dynavax Technologies Corp.

Provide EV/S
for Dynavax Technologies Corp.

Provide EV/GP
for Dynavax Technologies Corp.

Provide EV/EBITDA
for Dynavax Technologies Corp.

Provide EV/EBIT
for Dynavax Technologies Corp.

Provide EV/OCF
for Dynavax Technologies Corp.

Provide EV/FCFF
for Dynavax Technologies Corp.

Provide EV/IC
for Dynavax Technologies Corp.

Show me price targets
for Dynavax Technologies Corp made by professional analysts.

What are the Revenue projections
for Dynavax Technologies Corp?

How accurate were the past Revenue estimates
for Dynavax Technologies Corp?

What are the Net Income projections
for Dynavax Technologies Corp?

How accurate were the past Net Income estimates
for Dynavax Technologies Corp?

What are the EPS projections
for Dynavax Technologies Corp?

How accurate were the past EPS estimates
for Dynavax Technologies Corp?

What are the EBIT projections
for Dynavax Technologies Corp?

How accurate were the past EBIT estimates
for Dynavax Technologies Corp?

Compare the revenue forecasts
for Dynavax Technologies Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dynavax Technologies Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dynavax Technologies Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dynavax Technologies Corp compared to its peers.

Compare the P/E ratios
of Dynavax Technologies Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Dynavax Technologies Corp with its peers.

Analyze the financial leverage
of Dynavax Technologies Corp compared to its main competitors.

Show all profitability ratios
for Dynavax Technologies Corp.

Provide ROE
for Dynavax Technologies Corp.

Provide ROA
for Dynavax Technologies Corp.

Provide ROIC
for Dynavax Technologies Corp.

Provide ROCE
for Dynavax Technologies Corp.

Provide Gross Margin
for Dynavax Technologies Corp.

Provide Operating Margin
for Dynavax Technologies Corp.

Provide Net Margin
for Dynavax Technologies Corp.

Provide FCF Margin
for Dynavax Technologies Corp.

Show all solvency ratios
for Dynavax Technologies Corp.

Provide D/E Ratio
for Dynavax Technologies Corp.

Provide D/A Ratio
for Dynavax Technologies Corp.

Provide Interest Coverage Ratio
for Dynavax Technologies Corp.

Provide Altman Z-Score Ratio
for Dynavax Technologies Corp.

Provide Quick Ratio
for Dynavax Technologies Corp.

Provide Current Ratio
for Dynavax Technologies Corp.

Provide Cash Ratio
for Dynavax Technologies Corp.

What is the historical Revenue growth
over the last 5 years for Dynavax Technologies Corp?

What is the historical Net Income growth
over the last 5 years for Dynavax Technologies Corp?

What is the current Free Cash Flow
of Dynavax Technologies Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dynavax Technologies Corp.

P/E
Price to Earnings

81.2

Current

13.7

Median

22.7

Industry

Higher than median

Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

81.2

Market Cap

1.7B USD

Net Income

20.5m USD

All Countries

Forward Multiples

			Market Cap	P/E
US		Dynavax Technologies Corp NASDAQ:DVAX	1.7B USD	81.2
FR		Pharnext SCA OTC:PNEXF	6T USD	-179 646.3
US		Abbvie Inc NYSE:ABBV	320.1B USD	63
US		Amgen Inc NASDAQ:AMGN	147.4B USD	34.9
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	119.4B USD	-248.8
US		Gilead Sciences Inc NASDAQ:GILD	113.8B USD	903.4
US	E	Epizyme Inc F:EPE	94.1B EUR	-475.6
AU		CSL Ltd ASX:CSL	135.4B AUD	33.1
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	82.6B USD	17.8
US	S	Seagen Inc F:SGT	39.3B EUR	-55.1
NL		argenx SE XBRU:ARGX	34.3B EUR	-130

				Earnings Growth
US		Dynavax Technologies Corp NASDAQ:DVAX	Average P/E: 188.9 81.2	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -179 646.3	N/A
US		Abbvie Inc NYSE:ABBV	63	412%
US		Amgen Inc NASDAQ:AMGN	34.9	73%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -248.8	42%
US		Gilead Sciences Inc NASDAQ:GILD	903.4	75%
US	E	Epizyme Inc F:EPE	Negative Multiple: -475.6	N/A
AU		CSL Ltd ASX:CSL	33.1	65%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	17.8	43%
US	S	Seagen Inc F:SGT	Negative Multiple: -55.1	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -130	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

2-Years Forward

P/E

33.7

3-Years Forward

P/E

25.9

Dynavax Technologies Corp
NASDAQ:DVAX

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Dynavax Technologies Corp NASDAQ:DVAX

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Dynavax Technologies Corp
NASDAQ:DVAX

P/E
Price to Earnings